TLR2 is one of the endothelial receptors for β2-glycoprotein I

Journal of Immunology

Volumn 185, Issue 3, 2010, Pages 1550-1557

  Alard, Jean Eric ^a,b   Gaillard, Fanny ^d   Daridon, Capucine ^a,b,c   Shoenfeld, Yehuda ^e   Jamin, Christophe ^a,b,c   Youinou, Pierre ^a,b,c  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^b UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^c BREST UNIVERSITY HOSPITAL   (France)

^d CNRS   (France)

^e SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; PEPTIDE; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ARTICLE; BIOTINYLATION; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INTERNALIZATION; LIPID RAFT; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SURFACE PLASMON RESONANCE; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CATTLE; CELL LINE; CELL MEMBRANE; CELL STRAIN HEPG2; CELL STRAIN U937; IMMUNOLOGY; IMMUNOPRECIPITATION; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; VASCULAR ENDOTHELIUM;

AMINO ACID SEQUENCE; ANIMALS; BETA 2-GLYCOPROTEIN I; CATTLE; CELL LINE; ENDOTHELIUM, VASCULAR; HEP G2 CELLS; HUMANS; IMMUNOPRECIPITATION; MEMBRANE MICRODOMAINS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; U937 CELLS;

EID: 77956395908     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000526     Document Type: Article

References (55)

1. Hughes, G. R. V. 1993. The antiphospholipid syndrome: ten years on. Lancet 342: 341-344.
2. Shoenfeld, Y. 2007. APS - more systemic disease than SLE. Clin. Rev. Allergy Immunol. 32: 129-130.
3. Lockshin, M. D. 2008. Update on antiphospholipid syndrome. Bull. NYU Hosp. Jt. Dis. 66: 195-197.
4. McNeil, H. P., R. J. Simpson, C. N. Chesterman, and S. A. Krilis. 1990. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. USA 87: 4120-4124.
5. Galli, M., P. Comfurius, C. Maassen, H. C. Hemker, M. H. de Baets, P. J. van Breda-Vriesman, T. Barbui, R. F. Zwaal, and E. M. Bevers. 1990. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335: 1544-1547.
6. Matsuura, E., Y. Igarashi, M. Fujimoto, K. Ichikawa, and T. Koike. 1990. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336: 177-178. (Pubitemid 20225005)
7. Del Papa, N., Y. H. Sheng, E. Raschi, J. Lahnstein, S. A. Kandiah, A. Tincani, M. A. Khamashta, T. Atsumi, G. R. Hughes, K. Ichikawa, et al. 1998. Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies. J. Immunol. 160: 5572-5578. (Pubitemid 28267851)
8. Matsuura, E., Y. Igarashi, T. Yasuda, D. A. Triplett, and T. Koike. 1994. Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 179: 457-462.
9. Roubey, R. A., R. A. Eisenberg, M. F. Harper, and J. B. Winfield. 1995. "Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J. Immunol. 154: 954-960.
10. Pierangeli, S. S., M. Colden-Stanfield, X. Liu, J. H. Barker, G. L. Anderson, and E. N. Harris. 1999. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 99: 1997-2002.
11. Meroni, P. L., E. Raschi, C. Testoni, A. Tincani, G. Balestrieri, R. Molteni, M. A. Khamashta, E. Tremoli, and M. Camera. 2001. Statins prevent endothelial cell activation induced by anti-beta 2-glycoprotein I antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis Rheum. 44: 2870-2878.
12. Caronti, B., C. Calderaro, C. Alessandri, F. Conti, R. Tinghino, G. Palladini, and G. Valesini. 1999. Beta2-glycoprotein I mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage. Clin. Exp. Immunol. 115: 214-219.
13. Alvarado-de la Barrera, C., S. Bahena, L. Llorente, A. Martínez-Castillo, D. Alarcón-Segovia, and A. R. Cabral. 1998. Beta2-glycoprotein-I mRNA transcripts are expressed by hepatocytes but not by resting or activated human endothelial cells. Thromb. Res. 90: 239-243.
14. Sheng, Y., D. A. Kandiah, and S. A. Krilis. 1998. Anti-beta 2-glycoprotein I autoantibodies from patients with the " antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity. J. Immunol. 161: 2038-2043.
15. Bordron, A., M. Dueymes, Y. Levy, C. Jamin, J. P. Leroy, J. C. Piette, Y. Shoenfeld, and P. Youinou. 1998. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J. Clin. Invest. 101: 2029-2035.
16. Bordron, A., M. Dueymes, Y. Levy, C. Jamin, L. Ziporen, J. C. Piette, Y. Shoenfeld, and P. Youinou. 1998.Antiendothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. Arthritis Rheum. 41: 1738-1747. (Pubitemid 28465528)
17. Sheng, Y., A. Sali, H. Herzog, J. Lahnstein, and S. A. Krilis. 1996. Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J. Immunol. 157: 3744-3751.
18. Hamdan, R., S. N. Maiti, and A. J. Schroit. 2007. Interaction of beta2-glycoprotein 1 with phosphatidylserine-containing membranes: ligand-dependent conformational alterations initiate bivalent binding. Biochemistry 46: 10612-10620.
19. Moestrup, S. K., I. Schousboe, C. Jacobsen, J. R. Leheste, E. I. Christensen, and T. E. Willnow. 1998. beta 2-glycoprotein I (apolipoprotein H) and beta 2-glycoprotein I-phospholipid complex harbor a recognition site for the endocytic receptor megalin. J. Clin. Invest. 102: 902-909.
20. Ma, K., R. Simantov, J. C. Zhang, R. Silverstein, K. A. Hajjar, and K. R. McCrae. 2000. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J. Biol. Chem. 275: 15541-15548.
21. Lutters, B. C., R. H. Derksen, W. L. Tekelenburg, P. J. Lenting, J. Arnout, and P. G. de Groot. 2003. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2′. J. Biol. Chem. 278: 33831-33838.
22. Reed, J. H., B. Giannakopoulos, M. W. Jackson, S. A. Krilis, and T. P. Gordon. 2009. Ro 60 functions as a receptor for beta(2)-glycoprotein I on apoptotic cells. Arthritis Rheum. 60: 860-869.
23. Arnout, J., C. Wittevrongel, M. Vanrusselt, M. Hoylaerts, and J. Vermylen. 1998. Beta 2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta 2-glycoprotein I complexes on phospholipid surfaces. Thromb. Haemost. 79: 79-86.
24. Vega-Ostertag, M., K. Casper, R. Swerlick, D. Ferrara, E. N. Harris, and S. S. Pierangeli. 2005. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum. 52: 1545-1554.
25. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature 387: 569-572.
26. Pegu, A., S. Qin, B. A. Fallert Junecko, R. E. Nisato, M. S. Pepper, and T. A. Reinhart. 2008. Human lymphatic endothelial cells express multiple functional TLRs. J. Immunol. 180: 3399-3405.
27. Triantafilou, M., K. Miyake, D. T. Golenbock, and K. Triantafilou. 2002. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 115: 2603-2611. (Pubitemid 34778077)
28. Satta, N., S. Dunoyer-Geindre, G. Reber, R. J. Fish, F. Boehlen, E. K. Kruithof, and P. de Moerloose. 2007. The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood 109: 1507-1514. (Pubitemid 46239583)
29. Pierangeli, S. S., M. E. Vega-Ostertag, E. Raschi, X. Liu, Z. Romay-Penabad, V. De Micheli, M. Galli, M. Moia, A. Tincani, M. O. Borghi, et al. 2007. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann. Rheum. Dis. 66: 1327-1333.
30. Sorice, M., A. Longo, A. Capozzi, T. Garofalo, R. Misari, C. Alessandri, F. Conti, B. Buttari, R. Riganò, E. Ortona, and G. Valesini. 2007. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum. 56: 2687-2697. (Pubitemid 47237287)
31. Pierangeli, S. S. 2006. In search for a receptor for antiphospholipid antibodies on target cells. J. Thromb. Haemost. 4: 1678-1679.
32. Le Tonquèze, M., K. Salozhin, M. Dueymes, J. C. Piette, V. Kovalev, Y. Shoenfeld, E. Nassonov, and P. Youinou. 1995. Role of beta 2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Lupus 4: 179-186.
33. Edgell, C. J., C. C. McDonald, and J. B. Graham. 1983. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA 80: 3734-3737.
34. Tsutsumi-Ishii, Y., and I. Nagaoka. 2003. Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. J. Immunol. 170: 4226-4236. (Pubitemid 36428189)
35. Arvieux, J., P. Pouzol, B. Roussel, M. C. Jacob, and M. G. Colomb. 1992. Lupus-like anticoagulant properties of murine monoclonal antibodies to beta 2-glycoprotein I. Br. J. Haematol. 81: 568-573.
36. Kobayashi, T., E. Stang, K. S. Fang, P. de Moerloose, R. G. Parton, and J. Gruenberg. 1998. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature 392: 193-197. (Pubitemid 28162794)
37. Manders, E. M. M., F. J. Verbeek, and J. A. Aten. 1993. Measurement of colocalization of objects in dual-colour confocal images. J. Microsc. 169: 375-382.
38. Arvieux, J., B. Roussel, M. C. Jacob, and M. G. Colomb. 1991. Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen. J. Immunol. Methods 143: 223-229.
39. Roden, L. D., and D. G. Myszka. 1996. Global analysis of a macromolecular interaction measured on BIAcore. Biochem. Biophys. Res. Commun. 225: 1073-1077.
40. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16: 3-9.
41. Dunoyer-Geindre, S., E. K. Kruithof, B. Galve-de Rochemonteix, C. Rosnoblet, J. Gruenberg, G. Reber, and P. de Moerloose. 2001. Localization of beta2-glycoprotein 1 in late endosomes of human endothelial cells. Thromb. Haemost. 85: 903-907.
42. Sorice, M., D. Ferro, R. Misasi, V. Pittoni, A. Longo, A. Circella, T. Garofalo, R. Gradini, F. Violi, J. Gruenberg, and G. Valesini. 2002. Evidence for antico-agulant activity and beta2-GPI accumulation in late endosomes of endothelial cells induced by anti-LBPA antibodies. Thromb. Haemost. 87: 735-741.
43. Gushiken, F. C., A. Le, F. C. Arnett, and P. Thiagarajan. 2002. Polymorphisms beta2-glycoprotein I: phospholipid binding and multimeric structure. Thromb. Res. 108: 175-180.
44. Lutters, B. C., J. C. Meijers, R. H. Derksen, J. Arnout, and P. G. de Groot. 2001. Dimers of beta 2-glycoprotein I mimic the in vitro effects of beta 2-glycoprotein I-anti-beta 2-glycoprotein I antibody complexes. J. Biol. Chem. 276: 3060-3067.
45. Dupuy D'Angeac, A., I. Stefas, H. Graafland, F. De Lamotte, M. Rucheton, C. Palais, A. K. Eriksson, P. Bosc, C. Rosé, and R. Chicheportiche. 2006. Biotinylation of glycan chains in beta2 glycoprotein I induces dimerization of the molecule and its detection by the human autoimmune anti-cardiolipin antibody EY2C9. Biochem. J. 393: 117-127.
46. Deng, G. M., and G. C. Tsokos. 2008. Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation. J. Immunol. 181: 4019-4026.
47. Raschi, E., C. Testoni, D. Bosisio, M. O. Borghi, T. Koike, A. Mantovani, and P. L. Meroni. 2003. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 101: 3495-3500.
48. Blank, M., I. Krause, M. Fridkin, N. Keller, J. Kopolovic, I. Goldberg, A. Tobar, and Y. Shoenfeld. 2002. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J. Clin. Invest. 109: 797-804.
49. Buttari, B., E. Profumo, V. Mattei, A. Siracusano, E. Ortona, P. Margutti, B. Salvati, M. Sorice, and R. Riganò. 2005. Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response. Blood 106: 3880-3887. (Pubitemid 41739027)
50. Faure, E., L. Thomas, H. Xu, A. Medvedev, O. Equils, and M. Arditi. 2001. Bacterial lipopolysaccride and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-κB activation. J. Immunol. 166: 2018-2024. (Pubitemid 32114690)
51. Talreja, J., M. H. Kabir, M. B Filla, D. J. Stechschulte, and K. N. Dileepan. 2004. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components. Immunology 113: 224-233.
52. Yumoto, H., H. H. Chou, Y. Takahashi, M. Davey, F. C. Gibson, III, and C. A. Genco. 2005. Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of Toll-like receptor 4 by bacterial fimbria-dependent invasion. Infect. Immun. 73: 8050-8059.
53. Gerke, V., and S. E. Moss. 2002. Annexins: from structure to function. Physiol. Rev. 82: 331-371.
54. Pennings, M. T., M. van Lummel, R. H. Derksen, R. T. Urbanus, R. A. Romijn, P. J. Lenting, and P. G. de Groot. 2006. Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family. J. Thromb. Haemost. 4: 1680-1690.
55. Zhang, J., and K. R. McCrae. 2005. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood 105: 1964-1969.